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Introduction
Myocardial tagging using accelerated whole-heart 3D
CSPAMM is a tool to study myocardial wall motion
parameters like strain, shortening and rotation.
Wall motion is altered in many heart diseases leading to
heart failure.
One main column in therapy is beta-blockers while its
physical mechanisms are not entirely understood yet.
Differences in beta-blocker sensitivity of longitudinal and
transverse myocardial fibres seem to be of relevance.
We postulate a positive effect of early blocking of the con-
traction of the transverse myocardial fibres at low beta-
blocker dosages which leads to increased longitudinal
contractility with consecutively enhanced myocardial
function.
Purpose
MRI 3D-tagging is used to investigate the structural basic
principle in myocardial architecture accounting for the
effect of beta-blocker therapy in myocardial insufficiency.
Methods
We included 10 healthy adults and administered an infu-
sion of the beta-blocker Esmolol at increasing dosages
starting from 5 or 50 μg/kg/min to 150 μg/kg/min.
Using a 3 T Philips Archieva® R2.5.3 MRI and the Gyro-
tools® 3D-tagging software we performed a whole-heart
tagging scan with grid line interspace of 7 mm at each dos-
age.
In addition short axis CINE scans were performed to cap-
ture changes in systolic and diastolic ventricular volumes
and stroke volumes respectively.
Stroke volumes were verified by executing phase-contrast
MRI flow measurements in the ascending aorta.
During the MRI investigation ECG and blood pressure
were continuously monitored.
After 3D shift correction the tagging scans were evaluated
using TagTrack 1.5.2®.
In short axis views midventricular contours were drawn
and processed throughout all heart phases, results
exported as numeric values for circumferential and radial
shortening [%] and rotation [degrees] and displayed as
curves over time [heart phases].
Results
In six volunteers a shift of shortening curves towards ear-
lier heart phases (left-shift) and a decrease in the area-
under-the-curve (work) was noted. In three volunteers no
significant change in phase but decrease in amplitude and
work was observed. One proband showed a significant
right-shift (negative inotropy) from the start. This
proband was investigated a second time starting at a very
low dose of 5 μg/kg/min resulting in a left-shift up to 25
μg/kg/min and a reproducible right-shift from 50 to 150
μg/kg/min. Vital parameters remained stable at all dos-
ages in all volunteers.
Conclusion
Beta-blockers at low doses evoke an accelerated contrac-
tion profile leading to less myocardial work load with pro-
longed rest at diastole. At higher doses they induce
negative inotropy. Individual beta-blocker-sensitivity can
be detected by MRI 3D-tagging.
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